PL3418273T3 - Pochodne flawaglin - Google Patents
Pochodne flawaglinInfo
- Publication number
- PL3418273T3 PL3418273T3 PL18187037.9T PL18187037T PL3418273T3 PL 3418273 T3 PL3418273 T3 PL 3418273T3 PL 18187037 T PL18187037 T PL 18187037T PL 3418273 T3 PL3418273 T3 PL 3418273T3
- Authority
- PL
- Poland
- Prior art keywords
- flavagline derivatives
- flavagline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1456474A FR3023290B1 (fr) | 2014-07-04 | 2014-07-04 | Derives de flavaglines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3418273T3 true PL3418273T3 (pl) | 2022-08-01 |
Family
ID=52016681
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15733767T PL3164393T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
| PL18187037.9T PL3418273T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15733767T PL3164393T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10047064B2 (pl) |
| EP (3) | EP3418273B1 (pl) |
| JP (4) | JP6637954B2 (pl) |
| DK (2) | DK3418273T3 (pl) |
| ES (2) | ES2908225T3 (pl) |
| FR (1) | FR3023290B1 (pl) |
| PL (2) | PL3164393T3 (pl) |
| TR (1) | TR201819805T4 (pl) |
| WO (1) | WO2016001441A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
| ES2974439T3 (es) | 2015-11-25 | 2024-06-27 | Effector Therapeutics Inc | Compuestos inhibidores de EIF4-A y métodos relacionados con los mismos |
| LT3643707T (lt) * | 2017-06-19 | 2022-05-25 | Futurechem Co., Ltd. | 18f žymėtas junginys, skirtas prostatos vėžio diagnostikai ir jo panaudojimas |
| EP3755693B1 (en) * | 2018-02-19 | 2024-06-12 | Memorial Sloan-Kettering Cancer Center | Agents and methods for treating dysproliferative diseases |
| SI3773544T1 (sl) | 2018-04-10 | 2026-01-30 | Cellectar Biosciences, Inc. | Fosfolipid-flavaglin konjugati ter postopki njihove uporabe za ciljno zdravljenje raka |
| WO2020076889A1 (en) * | 2018-10-09 | 2020-04-16 | The Research Institute At Nationwide Children's Hospital | Anticancer rocaglamide derivatives |
| US11427595B2 (en) * | 2018-10-22 | 2022-08-30 | Trustees Of Boston University | Compositions and methods for inhibiting viral infection |
| JP7631329B2 (ja) * | 2019-10-10 | 2025-02-18 | セレクター・バイオサイエンシズ・インコーポレイテッド | リン脂質－フラバグリン抱合体及び標的化されたがん治療のためのリン脂質－フラバグリン抱合体の使用方法 |
| WO2025104293A1 (en) * | 2023-11-17 | 2025-05-22 | Gustave Roussy Transfert | Inhibitors of eif4a and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ866500A0 (en) * | 2000-07-05 | 2000-08-03 | Exgenix Operations Pty Ltd | Therapeutic compounds and methods |
| DE102004024504A1 (de) * | 2004-05-18 | 2006-02-16 | Bayer Healthcare Ag | Neue Cylopenta[b]benzofuran-Derivate und ihre Verwendung |
| CA2652873A1 (en) * | 2006-05-22 | 2007-12-06 | Trustees Of Boston University | Asymmetric synthesis of rocaglamides via enantioselective photocycloaddition mediated by chiral bronsted acids |
| EP2189453A1 (en) * | 2008-11-25 | 2010-05-26 | Université Louis Pasteur | Rocaglaol derivatives as cardioprotectant agents |
| JP2012510964A (ja) * | 2008-12-05 | 2012-05-17 | インターメッド・ディスカバリー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Ｈｉｆ−１蛋白蓄積の阻害剤 |
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
-
2014
- 2014-07-04 FR FR1456474A patent/FR3023290B1/fr active Active
-
2015
- 2015-07-06 TR TR2018/19805T patent/TR201819805T4/tr unknown
- 2015-07-06 DK DK18187037.9T patent/DK3418273T3/da active
- 2015-07-06 PL PL15733767T patent/PL3164393T3/pl unknown
- 2015-07-06 US US15/323,650 patent/US10047064B2/en active Active
- 2015-07-06 DK DK15733767.6T patent/DK3164393T3/en active
- 2015-07-06 EP EP18187037.9A patent/EP3418273B1/fr active Active
- 2015-07-06 WO PCT/EP2015/065294 patent/WO2016001441A1/fr not_active Ceased
- 2015-07-06 PL PL18187037.9T patent/PL3418273T3/pl unknown
- 2015-07-06 EP EP21213303.7A patent/EP3998257A1/fr active Pending
- 2015-07-06 ES ES18187037T patent/ES2908225T3/es active Active
- 2015-07-06 ES ES15733767T patent/ES2700156T3/es active Active
- 2015-07-06 EP EP15733767.6A patent/EP3164393B1/fr active Active
- 2015-07-06 JP JP2017500083A patent/JP6637954B2/ja active Active
-
2017
- 2017-12-01 US US15/829,630 patent/US10519125B2/en active Active
-
2019
- 2019-12-20 JP JP2019230768A patent/JP6951406B2/ja active Active
-
2021
- 2021-09-22 JP JP2021154798A patent/JP7340574B2/ja active Active
-
2023
- 2023-08-25 JP JP2023137552A patent/JP2023159393A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2908225T3 (es) | 2022-04-28 |
| EP3418273B1 (fr) | 2022-01-12 |
| EP3998257A1 (fr) | 2022-05-18 |
| JP6951406B2 (ja) | 2021-10-20 |
| EP3418273A1 (fr) | 2018-12-26 |
| DK3418273T3 (da) | 2022-03-21 |
| PL3164393T3 (pl) | 2019-03-29 |
| JP7340574B2 (ja) | 2023-09-07 |
| FR3023290A1 (fr) | 2016-01-08 |
| US20170137400A1 (en) | 2017-05-18 |
| JP2017519796A (ja) | 2017-07-20 |
| US20180086729A1 (en) | 2018-03-29 |
| ES2700156T3 (es) | 2019-02-14 |
| JP2022000455A (ja) | 2022-01-04 |
| JP6637954B2 (ja) | 2020-01-29 |
| US10519125B2 (en) | 2019-12-31 |
| DK3164393T3 (en) | 2019-01-21 |
| EP3164393A1 (fr) | 2017-05-10 |
| JP2020063289A (ja) | 2020-04-23 |
| JP2023159393A (ja) | 2023-10-31 |
| US10047064B2 (en) | 2018-08-14 |
| FR3023290B1 (fr) | 2016-08-19 |
| WO2016001441A1 (fr) | 2016-01-07 |
| EP3164393B1 (fr) | 2018-09-19 |
| TR201819805T4 (tr) | 2019-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3373003T3 (en) | Urinteststrimmel | |
| IL253381B (en) | History of h9–pyrrolo–dipyridine | |
| ZA201704602B (en) | Dihydroindolizinone derivative | |
| SG11201703187PA (en) | Carbazole derivatives | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3164393T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| SG11201608634RA (en) | Cycloalkyl-linked diheterocycle derivatives | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| HUE044703T2 (hu) | Új CYP-eikozanoid származékok | |
| IL248772A0 (en) | A consequence of cyclohexyl pyridine | |
| DK3194944T3 (en) | Tomografiapparat | |
| GB201401268D0 (en) | TrackPack | |
| GB201403931D0 (en) | Podoquick | |
| AU5585P (en) | Lanutah Mandevilla sanderi | |
| AU5594P (en) | Lanoregon Mandevilla sanderi | |
| AU5591P (en) | Lanmontana Mandevilla sanderi | |
| AU2014265V (en) | FlatdampGL Westringia dampieri | |
| AU358508S (en) | Bedhead | |
| AP00670S1 (en) | Legate | |
| AU2014072V (en) | Duemarre Mandevilla sanderi | |
| GB201404430D0 (en) | PiFlex | |
| GB201403319D0 (en) | Niripeyarchy |